Sung, Y., Cho, S., Kim, D., Won, S., Choi, C., Kim, T., . . . Bae, S. (2018). Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy. Korean J Intern Med.
Chicago Stili AlıntıSung, Yoon-Kyoung, Soo-Kyung Cho, Dam Kim, Soyoung Won, Chan-Bum Choi, Tae-Hwan Kim, Jae-Bum Jun, Dae-Hyun Yoo, ve Sang-Cheol Bae. "Isoniazid Treatment for Latent Tuberculosis Infection Is Tolerable for Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitor Therapy." Korean J Intern Med 2018.
MLA AlıntıSung, Yoon-Kyoung, et al. "Isoniazid Treatment for Latent Tuberculosis Infection Is Tolerable for Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitor Therapy." Korean J Intern Med 2018.